Moneycontrol PRO
HomeNewsHealth & Fitness3-Point Analysis | Why AstraZeneca's COVID vaccine may be more suitable for India than Pfizer, Moderna shots

3-Point Analysis | Why AstraZeneca's COVID vaccine may be more suitable for India than Pfizer, Moderna shots

Watch the video to find out how a dosing error turned into a lucky punch for AstraZeneca and Oxford.

November 24, 2020 / 14:40 IST
X

In another promising development in the quest to end the pandemic, a COVID-19 vaccine developed by Oxford-AstraZeneca has prevented a majority of people from getting the disease in a large trial. Watch the video to find out how a dosing error turned into a lucky punch for AstraZeneca and Oxford.

Moneycontrol News
first published: Nov 24, 2020 02:40 pm

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347